Rajesh Kumar
Stock Analyst at HSBC
(2.55)
# 2,326
Out of 4,966 analysts
23
Total ratings
60%
Success rate
12.54%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Upgrades: Hold | $675 → $700 | $732.58 | -4.45% | 3 | Aug 27, 2025 | |
| NVO Novo Nordisk | Downgrades: Hold | n/a | $56.46 | - | 1 | Jul 31, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $260 → $160 | $190.81 | -16.15% | 1 | Apr 25, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $29.09 | +44.38% | 1 | Apr 25, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $185 | $210.40 | -12.07% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $492.72 | +35.98% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $205.82 | +36.04% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $309.87 | +48.45% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $18.38 | -29.27% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $47.18 | +12.34% | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Reduce | $97 | $24.09 | +302.66% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $100.00 | +24.00% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $24.76 | +101.94% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $84.12 | +46.22% | 1 | Jul 14, 2023 |
Eli Lilly and Company
Aug 27, 2025
Upgrades: Hold
Price Target: $675 → $700
Current: $732.58
Upside: -4.45%
Novo Nordisk
Jul 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $56.46
Upside: -
IQVIA Holdings
Apr 25, 2025
Downgrades: Hold
Price Target: $260 → $160
Current: $190.81
Upside: -16.15%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $29.09
Upside: +44.38%
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $210.40
Upside: -12.07%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $492.72
Upside: +35.98%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $205.82
Upside: +36.04%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $309.87
Upside: +48.45%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $18.38
Upside: -29.27%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $47.18
Upside: +12.34%
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $24.09
Upside: +302.66%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $100.00
Upside: +24.00%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $24.76
Upside: +101.94%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $84.12
Upside: +46.22%